Small animal models |
Murine model of haematogenous pulmonary infection by intravenous injection of S. aureus enmeshed in agar beads |
Sawai et al. 12: animal model validation and role of coagulase (February 1997) |
Yanagihara et al. 13: efficacy of linezolid against methicillin-resistant or vancomycin-insensitive S. aureus (July 2002) |
Kaneko et al. 14: effects of DQ-113 against methicillin- and vancomycin-resistant S. aureus (August 2003) |
Yanagihara et al. 15: efficacy of quinpristin-dalfopristin against methicillin-resistant S. aureus and vancomycin-insensitive S. aureus (November 2004) |
Yanagihara et al. 16: potency of DX-619 against methicillin-resistant and vancomycin-intermediate S. aureus (March 2006) |
Yanagihara et al. 17: effects of short interfering RNA against methicillin-resistant S. aureus coagulase in vitro and in vivo (December 2005) |
Murine model of pulmonary infection by transnasal administration of S. aureus |
Kimura et al. 18: animal model validation and factors affecting the course and severity of pneumonia (November 1999) |
Bubeck Wardenburg et al. 19: surface proteins and exotoxins are required for the pathogenesis of S. aureus pneumonia (February 2007) |
Bubeck Wardenburg et al. 20: vaccine protection against S. aureus pneumonia (February 2008) |
Murine model of pulmonary infection by instillation into the lung of S. aureus in ventilated animals |
McElroy et al. 21: alpha-toxin damages the air–blood barrier (October 1999) |
Large animal models |
Ovine ventilated model of pulmonary infection by instillation by bronchoscope of S. aureus |
Enkhbaatar et al. 22: animal model validation (May 2008) |
Piglet ventilated model of pneumonia induced by instillation by broncoscope of S. aureus |
Sibila et al. 23: animal model validation (2007) |